Duality Biotherapeutics, Inc. (HK:9606)
:9606
9606 Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9606 Stock 12 Month Forecast
Average Price Target
HK$423.73
▲(36.34% Upside)
| Highest Price TargetHK$455.80 | Average Price TargetHK$423.73 | Lowest Price TargetHK$383.47 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
CMB International Securities
HK$383.47
Buy
23.38%
Upside
Reiterated
03/29/26
CLSA
HK$268.3
Buy
-13.67%
Downside
Initiated
05/22/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
CMB International Securities
HK$383.47
Buy
23.38%
Upside
Reiterated
03/29/26
CLSA
HK$268.3
Buy
-13.67%
Downside
Initiated
05/22/25
Best Analysts Covering Duality Biotherapeutics, Inc.
3 Months
xxx
Success Rate
2/2 ratings generated profit
Average Return
+39.60%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +39.60% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+31.10%
initiated a buy rating 11 months ago
Copying Matthew Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +31.10% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
Average Return
+11.20%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +11.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9606 Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Jan 26
Feb 26
Mar 26
Strong Buy
1
1
1
0
2
Buy
6
8
5
4
4
Hold
19
21
7
6
0
Sell
2
1
0
0
0
Strong Sell
0
0
0
0
0
total
28
31
13
10
6
Each month's total comprises the sum of three months' worth of ratings.
9606 Financial Forecast
9606 Stock Forecast FAQ
What is HK:9606’s average 12-month price target, according to analysts?
Based on analyst ratings, Duality Biotherapeutics, Inc.’s 12-month average price target is 423.73.
What is HK:9606’s upside potential, based on the analysts’ average price target?
Duality Biotherapeutics, Inc. has 36.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Duality Biotherapeutics, Inc. a Buy, Sell or Hold?
Duality Biotherapeutics, Inc. has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Duality Biotherapeutics, Inc.’s share price target?
The average share price target for Duality Biotherapeutics, Inc. is 423.73. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$455.80 ,and the lowest forecast is HK$383.47. The average share price target represents 36.34% Increase from the current price of HK$310.8.
The highest analyst share price target is HK$455.80 ,and the lowest forecast is HK$383.47. The average share price target represents 36.34% Increase from the current price of HK$310.8.
What do analysts say about Duality Biotherapeutics, Inc.?
Duality Biotherapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Duality Biotherapeutics, Inc.?
To buy shares of HK:9606, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.